speb/financial-data huggingface dataset:
UCL income_statement (quarterly, 2025-06-30) — Other Income Expense: 1011000.00
UCL balance_sheet (quarterly, 2025-06-30) — Other Non Current Liabilities: 59000.00
UCL income_statement (quarterly, 2025-06-30) — Other Non Operating Income Expenses: 1011000.00
UCL balance_sheet (quarterly, 2025-06-30) — Other Properties: 4849000.00
UCL balance_sheet (quarterly, 2025-06-30) — Other Short Term Investments: 8554000.00
UCL balance_sheet (quarterly, 2025-06-30) — Payables: 8025000.00
UCL balance_sheet (quarterly, 2025-06-30) — Payables And Accrued Expenses: 29866000.00
UCL income_statement (quarterly, 2025-06-30) — Pretax Income: 780000.00
UCL balance_sheet (quarterly, 2025-06-30) — Receivables: 6904000.00
UCL income_statement (quarterly, 2025-06-30) — Reconciled Cost Of Revenue: 9147000.00
UCL income_statement (quarterly, 2025-06-30) — Research And Development: 1566000.00
UCL balance_sheet (quarterly, 2025-06-30) — Retained Earnings: -221944000.00
UCL income_statement (quarterly, 2025-06-30) — Selling And Marketing Expense: 5503000.00
UCL income_statement (quarterly, 2025-06-30) — Selling General And Administration: 8866000.00
UCL balance_sheet (quarterly, 2025-06-30) — Share Issued: 377971590.00
UCL balance_sheet (quarterly, 2025-06-30) — Stockholders Equity: 22454000.00
UCL balance_sheet (quarterly, 2025-06-30) — Tangible Book Value: 21954000.00
UCL income_statement (quarterly, 2025-06-30) — Tax Effect Of Unusual Items: 0.00
UCL income_statement (quarterly, 2025-06-30) — Tax Provision: 95000.00
UCL income_statement (quarterly, 2025-06-30) — Tax Rate For Calcs: 0.12
UCL balance_sheet (quarterly, 2025-06-30) — Total Assets: 64728000.00
UCL balance_sheet (quarterly, 2025-06-30) — Total Capitalization: 22454000.00
UCL balance_sheet (quarterly, 2025-06-30) — Total Debt: 9939000.00
UCL balance_sheet (quarterly, 2025-06-30) — Total Equity Gross Minority Interest: 22454000.00
UCL income_statement (quarterly, 2025-06-30) — Total Expenses: 19579000.00
UCL balance_sheet (quarterly, 2025-06-30) — Total Liabilities Net Minority Interest: 42274000.00
UCL balance_sheet (quarterly, 2025-06-30) — Total Non Current Assets: 7359000.00
UCL balance_sheet (quarterly, 2025-06-30) — Total Non Current Liabilities Net Minority Interest: 501000.00
UCL income_statement (quarterly, 2025-06-30) — Total Operating Income As Reported: 808000.00
UCL balance_sheet (quarterly, 2025-06-30) — Working Capital: 15596000.00
UCL income_statement (quarterly, 2025-09-30) — +Operating Expense: 11208000.00
UCL income_statement (quarterly, 2025-09-30) — +Total Revenue: 21154000.00
UCL balance_sheet (quarterly, 2025-09-30) — Accounts Payable: 6395000.00
UCL balance_sheet (quarterly, 2025-09-30) — Accounts Receivable: 5760000.00
UCL balance_sheet (quarterly, 2025-09-30) — Additional Paid In Capital: 242255000.00
UCL income_statement (quarterly, 2025-09-30) — Basic Average Shares: 38014562.00
UCL income_statement (quarterly, 2025-09-30) — Basic EPS: 0.20
UCL cash_flow (quarterly, 2025-09-30) — Beginning Cash Position: 30204000.00
UCL balance_sheet (quarterly, 2025-09-30) — Capital Lease Obligations: 1508000.00
UCL balance_sheet (quarterly, 2025-09-30) — Capital Stock: 19000.00
UCL balance_sheet (quarterly, 2025-09-30) — Cash And Cash Equivalents: 28516000.00
UCL balance_sheet (quarterly, 2025-09-30) — Cash Cash Equivalents And Short Term Investments: 45799000.00
UCL cash_flow (quarterly, 2025-09-30) — Changes In Cash: -1732000.00
UCL balance_sheet (quarterly, 2025-09-30) — Common Stock: 19000.00
UCL balance_sheet (quarterly, 2025-09-30) — Common Stock Equity: 31733000.00
UCL income_statement (quarterly, 2025-09-30) — Cost Of Revenue: 9826000.00
UCL balance_sheet (quarterly, 2025-09-30) — Current Accrued Expenses: 20504000.00
UCL balance_sheet (quarterly, 2025-09-30) — Current Assets: 64302000.00
UCL balance_sheet (quarterly, 2025-09-30) — Current Capital Lease Obligation: 1223000.00
UCL balance_sheet (quarterly, 2025-09-30) — Current Debt: 6930000.00
UCL balance_sheet (quarterly, 2025-09-30) — Current Debt And Capital Lease Obligation: 8153000.00
UCL balance_sheet (quarterly, 2025-09-30) — Current Deferred Liabilities: 3229000.00
UCL balance_sheet (quarterly, 2025-09-30) — Current Deferred Revenue: 3229000.00
UCL balance_sheet (quarterly, 2025-09-30) — Current Liabilities: 38290000.00
UCL income_statement (quarterly, 2025-09-30) — Diluted Average Shares: 38014562.00
UCL income_statement (quarterly, 2025-09-30) — Diluted EPS: 0.20
UCL income_statement (quarterly, 2025-09-30) — Diluted NI Availto Com Stockholders: 9306000.00
UCL balance_sheet (quarterly, 2025-09-30) — Duefrom Related Parties Current: 612000.00
UCL balance_sheet (quarterly, 2025-09-30) — Dueto Related Parties Current: 9000.00
UCL income_statement (quarterly, 2025-09-30) — EBIT: 9254000.00
UCL income_statement (quarterly, 2025-09-30) — EBITDA: 9254000.00
UCL income_statement (quarterly, 2025-09-30) — Earnings From Equity Interest Net Of Tax: 1000.00
UCL cash_flow (quarterly, 2025-09-30) — Effect Of Exchange Rate Changes: 44000.00
UCL cash_flow (quarterly, 2025-09-30) — End Cash Position: 28516000.00
UCL cash_flow (quarterly, 2025-09-30) — Financing Cash Flow: -298000.00
UCL cash_flow (quarterly, 2025-09-30) — Free Cash Flow: -898000.00
UCL balance_sheet (quarterly, 2025-09-30) — Gains Losses Not Affecting Retained Earnings: 2097000.00
UCL income_statement (quarterly, 2025-09-30) — General And Administrative Expense: 3038000.00
UCL balance_sheet (quarterly, 2025-09-30) — Goodwill And Other Intangible Assets: 532000.00
UCL balance_sheet (quarterly, 2025-09-30) — Gross PPE: 4285000.00
UCL income_statement (quarterly, 2025-09-30) — Gross Profit: 11328000.00
UCL income_statement (quarterly, 2025-09-30) — Interest Expense: 21000.00
UCL income_statement (quarterly, 2025-09-30) — Interest Expense Non Operating: 21000.00
UCL income_statement (quarterly, 2025-09-30) — Interest Income: 11000.00
UCL income_statement (quarterly, 2025-09-30) — Interest Income Non Operating: 11000.00
UCL balance_sheet (quarterly, 2025-09-30) — Inventory: 4779000.00
UCL balance_sheet (quarterly, 2025-09-30) — Invested Capital: 39457000.00
UCL cash_flow (quarterly, 2025-09-30) — Investing Cash Flow: -536000.00
UCL balance_sheet (quarterly, 2025-09-30) — Investments And Advances: 2027000.00
UCL balance_sheet (quarterly, 2025-09-30) — Long Term Capital Lease Obligation: 285000.00
UCL balance_sheet (quarterly, 2025-09-30) — Long Term Debt: 794000.00
UCL balance_sheet (quarterly, 2025-09-30) — Long Term Debt And Capital Lease Obligation: 1079000.00
UCL income_statement (quarterly, 2025-09-30) — Net Income: 9306000.00
UCL income_statement (quarterly, 2025-09-30) — Net Income Common Stockholders: 9306000.00
UCL income_statement (quarterly, 2025-09-30) — Net Income Continuous Operations: 9306000.00
UCL income_statement (quarterly, 2025-09-30) — Net Income From Continuing And Discontinued Operation: 9306000.00
UCL income_statement (quarterly, 2025-09-30) — Net Income From Continuing Operation Net Minority Interest: 9306000.00
UCL income_statement (quarterly, 2025-09-30) — Net Income Including Noncontrolling Interests: 9306000.00
UCL income_statement (quarterly, 2025-09-30) — Net Interest Income: -10000.00
UCL income_statement (quarterly, 2025-09-30) — Net Non Operating Interest Income Expense: -10000.00
UCL balance_sheet (quarterly, 2025-09-30) — Net PPE: 4285000.00
UCL balance_sheet (quarterly, 2025-09-30) — Net Tangible Assets: 31201000.00
UCL income_statement (quarterly, 2025-09-30) — Normalized EBITDA: 9254000.00
UCL income_statement (quarterly, 2025-09-30) — Normalized Income: 9306000.00
UCL cash_flow (quarterly, 2025-09-30) — Operating Cash Flow: -898000.00
UCL income_statement (quarterly, 2025-09-30) — Operating Income: 120000.00
UCL income_statement (quarterly, 2025-09-30) — Operating Revenue: 21154000.00
UCL balance_sheet (quarterly, 2025-09-30) — Ordinary Shares Number: 377971590.00
UCL balance_sheet (quarterly, 2025-09-30) — Other Current Assets: 7352000.00
UCL balance_sheet (quarterly, 2025-09-30) — Other Current Borrowings: 6930000.00
UCL balance_sheet (quarterly, 2025-09-30) — Other Equity Adjustments: 2097000.00
UCL income_statement (quarterly, 2025-09-30) — Other Gand A: 3038000.00
UCL income_statement (quarterly, 2025-09-30) — Other Income Expense: 9123000.00
UCL balance_sheet (quarterly, 2025-09-30) — Other Non Current Liabilities: 44000.00
UCL income_statement (quarterly, 2025-09-30) — Other Non Operating Income Expenses: 9123000.00
UCL balance_sheet (quarterly, 2025-09-30) — Other Properties: 4285000.00
UCL balance_sheet (quarterly, 2025-09-30) — Other Short Term Investments: 17283000.00
UCL balance_sheet (quarterly, 2025-09-30) — Payables: 6404000.00
UCL balance_sheet (quarterly, 2025-09-30) — Payables And Accrued Expenses: 26908000.00
UCL income_statement (quarterly, 2025-09-30) — Pretax Income: 9233000.00
UCL balance_sheet (quarterly, 2025-09-30) — Receivables: 6372000.00
UCL income_statement (quarterly, 2025-09-30) — Reconciled Cost Of Revenue: 9826000.00
UCL income_statement (quarterly, 2025-09-30) — Research And Development: 1478000.00
UCL balance_sheet (quarterly, 2025-09-30) — Retained Earnings: -212638000.00
UCL income_statement (quarterly, 2025-09-30) — Selling And Marketing Expense: 6692000.00
UCL income_statement (quarterly, 2025-09-30) — Selling General And Administration: 9730000.00
UCL balance_sheet (quarterly, 2025-09-30) — Share Issued: 377971590.00
UCL balance_sheet (quarterly, 2025-09-30) — Stockholders Equity: 31733000.00
UCL balance_sheet (quarterly, 2025-09-30) — Tangible Book Value: 31201000.00
UCL income_statement (quarterly, 2025-09-30) — Tax Effect Of Unusual Items: 0.00
UCL income_statement (quarterly, 2025-09-30) — Tax Provision: -72000.00
UCL income_statement (quarterly, 2025-09-30) — Tax Rate For Calcs: 0.23
UCL balance_sheet (quarterly, 2025-09-30) — Total Assets: 71146000.00
UCL balance_sheet (quarterly, 2025-09-30) — Total Capitalization: 32527000.00
UCL balance_sheet (quarterly, 2025-09-30) — Total Debt: 9232000.00
UCL balance_sheet (quarterly, 2025-09-30) — Total Equity Gross Minority Interest: 31733000.00
UCL income_statement (quarterly, 2025-09-30) — Total Expenses: 21034000.00
UCL balance_sheet (quarterly, 2025-09-30) — Total Liabilities Net Minority Interest: 39413000.00
UCL balance_sheet (quarterly, 2025-09-30) — Total Non Current Assets: 6844000.00
UCL balance_sheet (quarterly, 2025-09-30) — Total Non Current Liabilities Net Minority Interest: 1123000.00
UCL income_statement (quarterly, 2025-09-30) — Total Operating Income As Reported: 9243000.00
UCL balance_sheet (quarterly, 2025-09-30) — Working Capital: 26012000.00
UCL income_statement (annual, 2025-12-31) — +Operating Expense: 40737000.00
UCL income_statement (quarterly, 2025-12-31) — +Operating Expense: 8865000.00
UCL income_statement (annual, 2025-12-31) — +Total Revenue: 81449000.00
UCL income_statement (quarterly, 2025-12-31) — +Total Revenue: 22170000.00
UCL balance_sheet (annual, 2025-12-31) — Accounts Payable: 7193000.00
UCL balance_sheet (quarterly, 2025-12-31) — Accounts Payable: 7193000.00
UCL balance_sheet (annual, 2025-12-31) — Accounts Receivable: 4436000.00
UCL balance_sheet (quarterly, 2025-12-31) — Accounts Receivable: 4436000.00
UCL balance_sheet (annual, 2025-12-31) — Accumulated Depreciation: -10330000.00
UCL balance_sheet (quarterly, 2025-12-31) — Accumulated Depreciation: -10330000.00
UCL balance_sheet (annual, 2025-12-31) — Additional Paid In Capital: 242421000.00
UCL balance_sheet (quarterly, 2025-12-31) — Additional Paid In Capital: 242421000.00
UCL balance_sheet (annual, 2025-12-31) — Allowance For Doubtful Accounts Receivable: -4596000.00
UCL balance_sheet (quarterly, 2025-12-31) — Allowance For Doubtful Accounts Receivable: -4596000.00
UCL cash_flow (annual, 2025-12-31) — Amortization Cash Flow: 129000.00
UCL cash_flow (annual, 2025-12-31) — Amortization Of Intangibles: 129000.00
UCL cash_flow (annual, 2025-12-31) — Asset Impairment Charge: -103000.00
UCL income_statement (annual, 2025-12-31) — Basic Average Shares: 37854684.00
UCL income_statement (quarterly, 2025-12-31) — Basic Average Shares: 38057266.00
UCL income_statement (annual, 2025-12-31) — Basic EPS: 0.20
UCL income_statement (quarterly, 2025-12-31) — Basic EPS: -0.10
UCL cash_flow (annual, 2025-12-31) — Beginning Cash Position: 30057000.00
UCL cash_flow (quarterly, 2025-12-31) — Beginning Cash Position: 28516000.00
UCL cash_flow (annual, 2025-12-31) — Capital Expenditure: -1046000.00
UCL balance_sheet (annual, 2025-12-31) — Capital Lease Obligations: 1763000.00
UCL balance_sheet (quarterly, 2025-12-31) — Capital Lease Obligations: 1763000.00
UCL balance_sheet (annual, 2025-12-31) — Capital Stock: 19000.00
UCL balance_sheet (quarterly, 2025-12-31) — Capital Stock: 19000.00
UCL balance_sheet (annual, 2025-12-31) — Cash And Cash Equivalents: 32831000.00
UCL balance_sheet (quarterly, 2025-12-31) — Cash And Cash Equivalents: 32831000.00
UCL balance_sheet (annual, 2025-12-31) — Cash Cash Equivalents And Short Term Investments: 46177000.00
UCL balance_sheet (quarterly, 2025-12-31) — Cash Cash Equivalents And Short Term Investments: 46177000.00
UCL cash_flow (annual, 2025-12-31) — Cash Flow From Continuing Financing Activities: 122000.00
UCL cash_flow (annual, 2025-12-31) — Cash Flow From Continuing Investing Activities: -1028000.00
UCL cash_flow (annual, 2025-12-31) — Cash Flow From Continuing Operating Activities: 3208000.00
UCL cash_flow (annual, 2025-12-31) — Change In Accrued Expense: -6304000.00
UCL cash_flow (annual, 2025-12-31) — Change In Inventory: -2986000.00
UCL cash_flow (annual, 2025-12-31) — Change In Other Current Liabilities: -76000.00
UCL cash_flow (annual, 2025-12-31) — Change In Other Working Capital: 2716000.00
UCL cash_flow (annual, 2025-12-31) — Change In Payable: -49000.00
UCL cash_flow (annual, 2025-12-31) — Change In Payables And Accrued Expense: -6353000.00
UCL cash_flow (annual, 2025-12-31) — Change In Prepaid Assets: 379000.00
UCL cash_flow (annual, 2025-12-31) — Change In Receivables: 3745000.00
UCL cash_flow (annual, 2025-12-31) — Change In Working Capital: -2575000.00
UCL cash_flow (annual, 2025-12-31) — Changes In Account Receivables: 3471000.00
UCL cash_flow (annual, 2025-12-31) — Changes In Cash: 2302000.00
UCL cash_flow (quarterly, 2025-12-31) — Changes In Cash: 4199000.00
UCL balance_sheet (annual, 2025-12-31) — Common Stock: 19000.00
UCL balance_sheet (quarterly, 2025-12-31) — Common Stock: 19000.00
UCL balance_sheet (annual, 2025-12-31) — Common Stock Equity: 28808000.00
UCL balance_sheet (quarterly, 2025-12-31) — Common Stock Equity: 28808000.00
UCL income_statement (annual, 2025-12-31) — Cost Of Revenue: 38766000.00
UCL income_statement (quarterly, 2025-12-31) — Cost Of Revenue: 10734000.00
UCL balance_sheet (annual, 2025-12-31) — Current Accrued Expenses: 17364000.00
UCL balance_sheet (quarterly, 2025-12-31) — Current Accrued Expenses: 17364000.00
UCL balance_sheet (annual, 2025-12-31) — Current Assets: 61262000.00
UCL balance_sheet (quarterly, 2025-12-31) — Current Assets: 61262000.00
UCL balance_sheet (annual, 2025-12-31) — Current Capital Lease Obligation: 1189000.00
UCL balance_sheet (quarterly, 2025-12-31) — Current Capital Lease Obligation: 1189000.00
UCL balance_sheet (annual, 2025-12-31) — Current Debt: 5617000.00
UCL balance_sheet (quarterly, 2025-12-31) — Current Debt: 5617000.00
UCL balance_sheet (annual, 2025-12-31) — Current Debt And Capital Lease Obligation: 6806000.00
UCL balance_sheet (quarterly, 2025-12-31) — Current Debt And Capital Lease Obligation: 6806000.00
UCL balance_sheet (annual, 2025-12-31) — Current Deferred Liabilities: 3425000.00
UCL balance_sheet (quarterly, 2025-12-31) — Current Deferred Liabilities: 3425000.00
UCL balance_sheet (annual, 2025-12-31) — Current Deferred Revenue: 3425000.00
UCL balance_sheet (quarterly, 2025-12-31) — Current Deferred Revenue: 3425000.00
UCL balance_sheet (annual, 2025-12-31) — Current Liabilities: 36767000.00
UCL balance_sheet (quarterly, 2025-12-31) — Current Liabilities: 36767000.00
UCL cash_flow (annual, 2025-12-31) — Depreciation: 2680000.00
UCL cash_flow (annual, 2025-12-31) — Depreciation Amortization Depletion: 2809000.00
UCL cash_flow (annual, 2025-12-31) — Depreciation And Amortization: 2809000.00
UCL income_statement (annual, 2025-12-31) — Diluted Average Shares: 37854684.00
UCL income_statement (quarterly, 2025-12-31) — Diluted Average Shares: 38057266.00
UCL income_statement (annual, 2025-12-31) — Diluted EPS: 0.20
UCL income_statement (quarterly, 2025-12-31) — Diluted EPS: -0.10
UCL income_statement (annual, 2025-12-31) — Diluted NI Availto Com Stockholders: 6301000.00
UCL income_statement (quarterly, 2025-12-31) — Diluted NI Availto Com Stockholders: -3069000.00
UCL cash_flow (annual, 2025-12-31) — Dividends Received Cfi: 0.00
UCL balance_sheet (annual, 2025-12-31) — Duefrom Related Parties Current: 1697000.00
UCL balance_sheet (quarterly, 2025-12-31) — Duefrom Related Parties Current: 1697000.00
UCL balance_sheet (annual, 2025-12-31) — Dueto Related Parties Current: 0.00
UCL balance_sheet (quarterly, 2025-12-31) — Dueto Related Parties Current: 0.00
UCL income_statement (annual, 2025-12-31) — EBIT: 8034000.00
UCL income_statement (quarterly, 2025-12-31) — EBIT: -1592000.00
UCL income_statement (annual, 2025-12-31) — EBITDA: 10843000.00
UCL income_statement (quarterly, 2025-12-31) — EBITDA: -1592000.00
UCL income_statement (annual, 2025-12-31) — Earnings From Equity Interest Net Of Tax: -12000.00
UCL income_statement (quarterly, 2025-12-31) — Earnings From Equity Interest Net Of Tax: -3000.00
UCL cash_flow (annual, 2025-12-31) — Earnings Losses From Equity Investments: 12000.00
UCL cash_flow (annual, 2025-12-31) — Effect Of Exchange Rate Changes: 472000.00
UCL cash_flow (quarterly, 2025-12-31) — Effect Of Exchange Rate Changes: 116000.00
UCL cash_flow (annual, 2025-12-31) — End Cash Position: 32831000.00
UCL cash_flow (quarterly, 2025-12-31) — End Cash Position: 32831000.00
UCL cash_flow (annual, 2025-12-31) — Financing Cash Flow: 122000.00
UCL cash_flow (quarterly, 2025-12-31) — Financing Cash Flow: -556000.00
UCL balance_sheet (annual, 2025-12-31) — Finished Goods: 3548000.00
UCL balance_sheet (quarterly, 2025-12-31) — Finished Goods: 3548000.00
UCL cash_flow (annual, 2025-12-31) — Free Cash Flow: 2162000.00
UCL cash_flow (quarterly, 2025-12-31) — Free Cash Flow: 3701000.00
UCL cash_flow (annual, 2025-12-31) — Gain Loss On Sale Of PPE: -104000.00
UCL income_statement (annual, 2025-12-31) — Gain On Sale Of Ppe: 104000.00
UCL income_statement (annual, 2025-12-31) — Gain On Sale Of Security: 5161000.00
UCL balance_sheet (annual, 2025-12-31) — Gains Losses Not Affecting Retained Earnings: 2075000.00
UCL balance_sheet (quarterly, 2025-12-31) — Gains Losses Not Affecting Retained Earnings: 2075000.00
UCL income_statement (annual, 2025-12-31) — General And Administrative Expense: 12577000.00
UCL income_statement (quarterly, 2025-12-31) — General And Administrative Expense: 3036000.00
UCL balance_sheet (annual, 2025-12-31) — Goodwill And Other Intangible Assets: 511000.00
UCL balance_sheet (quarterly, 2025-12-31) — Goodwill And Other Intangible Assets: 511000.00
UCL balance_sheet (annual, 2025-12-31) — Gross Accounts Receivable: 9032000.00
UCL balance_sheet (quarterly, 2025-12-31) — Gross Accounts Receivable: 9032000.00
UCL balance_sheet (annual, 2025-12-31) — Gross PPE: 14299000.00
UCL balance_sheet (quarterly, 2025-12-31) — Gross PPE: 14299000.00
UCL income_statement (annual, 2025-12-31) — Gross Profit: 42683000.00
UCL income_statement (quarterly, 2025-12-31) — Gross Profit: 11436000.00
UCL income_statement (annual, 2025-12-31) — Interest Expense: 196000.00
UCL income_statement (quarterly, 2025-12-31) — Interest Expense: 59000.00
UCL income_statement (annual, 2025-12-31) — Interest Expense Non Operating: 196000.00
UCL income_statement (quarterly, 2025-12-31) — Interest Expense Non Operating: 59000.00
UCL income_statement (annual, 2025-12-31) — Interest Income: 68000.00
UCL income_statement (quarterly, 2025-12-31) — Interest Income: 21000.00
UCL income_statement (annual, 2025-12-31) — Interest Income Non Operating: 68000.00
UCL income_statement (quarterly, 2025-12-31) — Interest Income Non Operating: 21000.00
UCL cash_flow (annual, 2025-12-31) — Interest Paid Supplemental Data: 196000.00
UCL balance_sheet (annual, 2025-12-31) — Inventories Adjustments Allowances: -1406000.00
UCL balance_sheet (quarterly, 2025-12-31) — Inventories Adjustments Allowances: -1406000.00
UCL balance_sheet (annual, 2025-12-31) — Inventory: 4378000.00
UCL balance_sheet (quarterly, 2025-12-31) — Inventory: 4378000.00
UCL balance_sheet (annual, 2025-12-31) — Invested Capital: 36047000.00
UCL balance_sheet (quarterly, 2025-12-31) — Invested Capital: 36047000.00
UCL cash_flow (annual, 2025-12-31) — Investing Cash Flow: -1028000.00
UCL cash_flow (quarterly, 2025-12-31) — Investing Cash Flow: 8000.00
UCL balance_sheet (annual, 2025-12-31) — Investments And Advances: 2044000.00
UCL balance_sheet (quarterly, 2025-12-31) — Investments And Advances: 2044000.00
UCL cash_flow (annual, 2025-12-31) — Issuance Of Debt: 7211000.00
UCL balance_sheet (annual, 2025-12-31) — Leases: 552000.00
UCL balance_sheet (quarterly, 2025-12-31) — Leases: 552000.00
UCL balance_sheet (annual, 2025-12-31) — Line Of Credit: 5549000.00
UCL balance_sheet (quarterly, 2025-12-31) — Line Of Credit: 5549000.00
UCL balance_sheet (annual, 2025-12-31) — Long Term Capital Lease Obligation: 574000.00
UCL balance_sheet (quarterly, 2025-12-31) — Long Term Capital Lease Obligation: 574000.00
UCL balance_sheet (annual, 2025-12-31) — Long Term Debt: 1622000.00
UCL balance_sheet (quarterly, 2025-12-31) — Long Term Debt: 1622000.00
UCL balance_sheet (annual, 2025-12-31) — Long Term Debt And Capital Lease Obligation: 2196000.00
UCL balance_sheet (quarterly, 2025-12-31) — Long Term Debt And Capital Lease Obligation: 2196000.00
UCL cash_flow (annual, 2025-12-31) — Long Term Debt Payments: 0.00
UCL balance_sheet (annual, 2025-12-31) — Machinery Furniture Equipment: 2378000.00
UCL balance_sheet (quarterly, 2025-12-31) — Machinery Furniture Equipment: 2378000.00
UCL cash_flow (annual, 2025-12-31) — Net Foreign Currency Exchange Gain Loss: -518000.00
UCL income_statement (annual, 2025-12-31) — Net Income: 6301000.00
UCL income_statement (quarterly, 2025-12-31) — Net Income: -3069000.00
UCL income_statement (annual, 2025-12-31) — Net Income Common Stockholders: 6301000.00
UCL income_statement (quarterly, 2025-12-31) — Net Income Common Stockholders: -3069000.00
UCL income_statement (annual, 2025-12-31) — Net Income Continuous Operations: 6301000.00
UCL income_statement (quarterly, 2025-12-31) — Net Income Continuous Operations: -3069000.00
UCL income_statement (annual, 2025-12-31) — Net Income From Continuing And Discontinued Operation: 6301000.00
UCL income_statement (quarterly, 2025-12-31) — Net Income From Continuing And Discontinued Operation: -3069000.00
UCL income_statement (annual, 2025-12-31) — Net Income From Continuing Operation Net Minority Interest: 6301000.00
UCL income_statement (quarterly, 2025-12-31) — Net Income From Continuing Operation Net Minority Interest: -3069000.00
UCL cash_flow (annual, 2025-12-31) — Net Income From Continuing Operations: 6301000.00
UCL income_statement (annual, 2025-12-31) — Net Income Including Noncontrolling Interests: 6301000.00
UCL income_statement (quarterly, 2025-12-31) — Net Income Including Noncontrolling Interests: -3069000.00
UCL cash_flow (annual, 2025-12-31) — Net Intangibles Purchase And Sale: -122000.00
UCL income_statement (annual, 2025-12-31) — Net Interest Income: -128000.00
UCL income_statement (quarterly, 2025-12-31) — Net Interest Income: -38000.00
UCL cash_flow (annual, 2025-12-31) — Net Investment Purchase And Sale: 0.00
UCL cash_flow (annual, 2025-12-31) — Net Issuance Payments Of Debt: 122000.00
UCL cash_flow (annual, 2025-12-31) — Net Long Term Debt Issuance: 0.00
UCL income_statement (annual, 2025-12-31) — Net Non Operating Interest Income Expense: -128000.00
UCL income_statement (quarterly, 2025-12-31) — Net Non Operating Interest Income Expense: -38000.00
UCL cash_flow (annual, 2025-12-31) — Net Other Investing Changes: -207000.00
UCL balance_sheet (annual, 2025-12-31) — Net PPE: 3969000.00
UCL balance_sheet (quarterly, 2025-12-31) — Net PPE: 3969000.00
UCL cash_flow (annual, 2025-12-31) — Net PPE Purchase And Sale: -699000.00
UCL cash_flow (annual, 2025-12-31) — Net Short Term Debt Issuance: 122000.00
UCL balance_sheet (annual, 2025-12-31) — Net Tangible Assets: 28297000.00
UCL balance_sheet (quarterly, 2025-12-31) — Net Tangible Assets: 28297000.00
UCL balance_sheet (annual, 2025-12-31) — Non Current Prepaid Assets: 43000.00
UCL balance_sheet (quarterly, 2025-12-31) — Non Current Prepaid Assets: 43000.00
UCL income_statement (annual, 2025-12-31) — Normalized EBITDA: 5578000.00
UCL income_statement (quarterly, 2025-12-31) — Normalized EBITDA: -1592000.00
UCL income_statement (annual, 2025-12-31) — Normalized Income: 2060384.41
UCL income_statement (quarterly, 2025-12-31) — Normalized Income: -3069000.00
UCL cash_flow (annual, 2025-12-31) — Operating Cash Flow: 3208000.00
UCL cash_flow (quarterly, 2025-12-31) — Operating Cash Flow: 4747000.00
UCL cash_flow (annual, 2025-12-31) — Operating Gains Losses: -610000.00
UCL income_statement (annual, 2025-12-31) — Operating Income: 1946000.00
UCL income_statement (quarterly, 2025-12-31) — Operating Income: 2571000.00
UCL income_statement (annual, 2025-12-31) — Operating Revenue: 81449000.00
UCL income_statement (quarterly, 2025-12-31) — Operating Revenue: 22170000.00
UCL balance_sheet (annual, 2025-12-31) — Ordinary Shares Number: 380572660.00
UCL balance_sheet (quarterly, 2025-12-31) — Ordinary Shares Number: 380572660.00
UCL balance_sheet (annual, 2025-12-31) — Other Current Assets: 189000.00
UCL balance_sheet (quarterly, 2025-12-31) — Other Current Assets: 189000.00
UCL balance_sheet (annual, 2025-12-31) — Other Current Borrowings: 68000.00
UCL balance_sheet (quarterly, 2025-12-31) — Other Current Borrowings: 68000.00
UCL balance_sheet (annual, 2025-12-31) — Other Current Liabilities: 1426000.00
UCL balance_sheet (quarterly, 2025-12-31) — Other Current Liabilities: 1426000.00
UCL balance_sheet (annual, 2025-12-31) — Other Equity Adjustments: 2075000.00
UCL balance_sheet (quarterly, 2025-12-31) — Other Equity Adjustments: 2075000.00
UCL income_statement (annual, 2025-12-31) — Other Gand A: 12577000.00
UCL income_statement (quarterly, 2025-12-31) — Other Gand A: 3036000.00
UCL income_statement (annual, 2025-12-31) — Other Income Expense: 6020000.00
UCL income_statement (quarterly, 2025-12-31) — Other Income Expense: -4184000.00
UCL balance_sheet (annual, 2025-12-31) — Other Intangible Assets: 511000.00
UCL balance_sheet (quarterly, 2025-12-31) — Other Intangible Assets: 511000.00
UCL balance_sheet (annual, 2025-12-31) — Other Investments: 2044000.00
UCL balance_sheet (quarterly, 2025-12-31) — Other Investments: 2044000.00
UCL cash_flow (annual, 2025-12-31) — Other Non Cash Items: 196000.00
UCL balance_sheet (annual, 2025-12-31) — Other Non Current Liabilities: 58000.00
UCL balance_sheet (quarterly, 2025-12-31) — Other Non Current Liabilities: 58000.00
UCL income_statement (annual, 2025-12-31) — Other Non Operating Income Expenses: 755000.00
UCL income_statement (quarterly, 2025-12-31) — Other Non Operating Income Expenses: -9449000.00
UCL income_statement (annual, 2025-12-31) — Other Operating Expenses: -694000.00
UCL balance_sheet (annual, 2025-12-31) — Other Properties: 11369000.00
UCL balance_sheet (quarterly, 2025-12-31) — Other Properties: 11369000.00
UCL balance_sheet (annual, 2025-12-31) — Other Short Term Investments: 13346000.00
UCL balance_sheet (quarterly, 2025-12-31) — Other Short Term Investments: 13346000.00
UCL balance_sheet (annual, 2025-12-31) — Payables: 7746000.00
UCL balance_sheet (quarterly, 2025-12-31) — Payables: 7746000.00
UCL balance_sheet (annual, 2025-12-31) — Payables And Accrued Expenses: 25110000.00
UCL balance_sheet (quarterly, 2025-12-31) — Payables And Accrued Expenses: 25110000.00
UCL balance_sheet (annual, 2025-12-31) — Prepaid Assets: 3026000.00
UCL balance_sheet (quarterly, 2025-12-31) — Prepaid Assets: 3026000.00
UCL income_statement (annual, 2025-12-31) — Pretax Income: 7838000.00
UCL income_statement (quarterly, 2025-12-31) — Pretax Income: -1651000.00
UCL cash_flow (annual, 2025-12-31) — Proceeds From Stock Option Exercised: 0.00
UCL balance_sheet (annual, 2025-12-31) — Properties: 0.00
UCL balance_sheet (quarterly, 2025-12-31) — Properties: 0.00
UCL cash_flow (annual, 2025-12-31) — Provisionand Write Offof Assets: 790000.00
UCL cash_flow (annual, 2025-12-31) — Purchase Of Intangibles: -122000.00
UCL cash_flow (annual, 2025-12-31) — Purchase Of PPE: -924000.00
UCL balance_sheet (annual, 2025-12-31) — Raw Materials: 2236000.00
UCL balance_sheet (quarterly, 2025-12-31) — Raw Materials: 2236000.00
UCL balance_sheet (annual, 2025-12-31) — Receivables: 7492000.00
UCL balance_sheet (quarterly, 2025-12-31) — Receivables: 7492000.00
UCL income_statement (annual, 2025-12-31) — Reconciled Cost Of Revenue: 38766000.00
UCL income_statement (quarterly, 2025-12-31) — Reconciled Cost Of Revenue: 10734000.00
UCL income_statement (annual, 2025-12-31) — Reconciled Depreciation: 2809000.00
UCL cash_flow (annual, 2025-12-31) — Repayment Of Debt: -7089000.00
UCL income_statement (annual, 2025-12-31) — Research And Development: 4868000.00
UCL income_statement (quarterly, 2025-12-31) — Research And Development: 425000.00
UCL balance_sheet (annual, 2025-12-31) — Retained Earnings: -215707000.00
UCL balance_sheet (quarterly, 2025-12-31) — Retained Earnings: -215707000.00
UCL cash_flow (annual, 2025-12-31) — Sale Of Investment: 0.00
UCL cash_flow (annual, 2025-12-31) — Sale Of PPE: 225000.00
UCL income_statement (annual, 2025-12-31) — Selling And Marketing Expense: 23986000.00
UCL income_statement (quarterly, 2025-12-31) — Selling And Marketing Expense: 6098000.00
UCL income_statement (annual, 2025-12-31) — Selling General And Administration: 36563000.00
UCL income_statement (quarterly, 2025-12-31) — Selling General And Administration: 9134000.00
UCL balance_sheet (annual, 2025-12-31) — Share Issued: 380572660.00
UCL balance_sheet (quarterly, 2025-12-31) — Share Issued: 380572660.00
UCL cash_flow (annual, 2025-12-31) — Short Term Debt Issuance: 7211000.00
UCL cash_flow (annual, 2025-12-31) — Short Term Debt Payments: -7089000.00
UCL income_statement (annual, 2025-12-31) — Special Income Charges: 104000.00
UCL cash_flow (annual, 2025-12-31) — Stock Based Compensation: 1043000.00
UCL balance_sheet (annual, 2025-12-31) — Stockholders Equity: 28808000.00
UCL balance_sheet (quarterly, 2025-12-31) — Stockholders Equity: 28808000.00
UCL balance_sheet (annual, 2025-12-31) — Tangible Book Value: 28297000.00
UCL balance_sheet (quarterly, 2025-12-31) — Tangible Book Value: 28297000.00
UCL income_statement (annual, 2025-12-31) — Tax Effect Of Unusual Items: 1024384.41
UCL income_statement (quarterly, 2025-12-31) — Tax Effect Of Unusual Items: 0.00
UCL income_statement (annual, 2025-12-31) — Tax Provision: 1525000.00
UCL income_statement (quarterly, 2025-12-31) — Tax Provision: 1415000.00
UCL income_statement (annual, 2025-12-31) — Tax Rate For Calcs: 0.19
UCL income_statement (quarterly, 2025-12-31) — Tax Rate For Calcs: 0.23
UCL balance_sheet (annual, 2025-12-31) — Taxes Receivable: 1359000.00
UCL balance_sheet (quarterly, 2025-12-31) — Taxes Receivable: 1359000.00
UCL balance_sheet (annual, 2025-12-31) — Total Assets: 67829000.00
UCL balance_sheet (quarterly, 2025-12-31) — Total Assets: 67829000.00
UCL balance_sheet (annual, 2025-12-31) — Total Capitalization: 30430000.00
UCL balance_sheet (quarterly, 2025-12-31) — Total Capitalization: 30430000.00
UCL balance_sheet (annual, 2025-12-31) — Total Debt: 9002000.00
UCL balance_sheet (quarterly, 2025-12-31) — Total Debt: 9002000.00
UCL balance_sheet (annual, 2025-12-31) — Total Equity Gross Minority Interest: 28808000.00
UCL balance_sheet (quarterly, 2025-12-31) — Total Equity Gross Minority Interest: 28808000.00
UCL income_statement (annual, 2025-12-31) — Total Expenses: 79503000.00
UCL income_statement (quarterly, 2025-12-31) — Total Expenses: 19599000.00
UCL balance_sheet (annual, 2025-12-31) — Total Liabilities Net Minority Interest: 39021000.00
UCL balance_sheet (quarterly, 2025-12-31) — Total Liabilities Net Minority Interest: 39021000.00
UCL balance_sheet (annual, 2025-12-31) — Total Non Current Assets: 6567000.00
UCL balance_sheet (quarterly, 2025-12-31) — Total Non Current Assets: 6567000.00
UCL balance_sheet (annual, 2025-12-31) — Total Non Current Liabilities Net Minority Interest: 2254000.00
UCL balance_sheet (quarterly, 2025-12-31) — Total Non Current Liabilities Net Minority Interest: 2254000.00
UCL income_statement (annual, 2025-12-31) — Total Operating Income As Reported: 7966000.00
UCL income_statement (quarterly, 2025-12-31) — Total Operating Income As Reported: -1613000.00
UCL balance_sheet (annual, 2025-12-31) — Total Tax Payable: 553000.00
UCL balance_sheet (quarterly, 2025-12-31) — Total Tax Payable: 553000.00
UCL income_statement (annual, 2025-12-31) — Total Unusual Items: 5265000.00
UCL income_statement (annual, 2025-12-31) — Total Unusual Items Excluding Goodwill: 5265000.00
UCL cash_flow (annual, 2025-12-31) — Unrealized Gain Loss On Investment Securities: -4643000.00
UCL balance_sheet (annual, 2025-12-31) — Working Capital: 24495000.00
UCL balance_sheet (quarterly, 2025-12-31) — Working Capital: 24495000.00
UCL income_statement (quarterly, 2026-03-31) — +Operating Expense: 10947000.00
UCL income_statement (quarterly, 2026-03-31) — +Total Revenue: 16859000.00
UCL balance_sheet (quarterly, 2026-03-31) — Accounts Payable: 3805000.00
UCL balance_sheet (quarterly, 2026-03-31) — Accounts Receivable: 4604000.00
UCL balance_sheet (quarterly, 2026-03-31) — Additional Paid In Capital: 242617000.00
UCL income_statement (quarterly, 2026-03-31) — Basic Average Shares: 38080410.00
UCL income_statement (quarterly, 2026-03-31) — Basic EPS: -0.10
UCL cash_flow (quarterly, 2026-03-31) — Beginning Cash Position: 32831000.00
UCL balance_sheet (quarterly, 2026-03-31) — Capital Lease Obligations: 1241000.00
UCL balance_sheet (quarterly, 2026-03-31) — Capital Stock: 19000.00
UCL balance_sheet (quarterly, 2026-03-31) — Cash And Cash Equivalents: 27998000.00
UCL balance_sheet (quarterly, 2026-03-31) — Cash Cash Equivalents And Short Term Investments: 40691000.00
UCL cash_flow (quarterly, 2026-03-31) — Changes In Cash: -5045000.00
UCL balance_sheet (quarterly, 2026-03-31) — Common Stock: 19000.00
UCL balance_sheet (quarterly, 2026-03-31) — Common Stock Equity: 25746000.00
UCL income_statement (quarterly, 2026-03-31) — Cost Of Revenue: 8586000.00
UCL balance_sheet (quarterly, 2026-03-31) — Current Accrued Expenses: 17993000.00
UCL balance_sheet (quarterly, 2026-03-31) — Current Assets: 56560000.00
UCL balance_sheet (quarterly, 2026-03-31) — Current Capital Lease Obligation: 780000.00
UCL balance_sheet (quarterly, 2026-03-31) — Current Debt: 9345000.00
UCL balance_sheet (quarterly, 2026-03-31) — Current Debt And Capital Lease Obligation: 10125000.00
UCL balance_sheet (quarterly, 2026-03-31) — Current Deferred Liabilities: 2315000.00
UCL balance_sheet (quarterly, 2026-03-31) — Current Deferred Revenue: 2315000.00
UCL balance_sheet (quarterly, 2026-03-31) — Current Liabilities: 34238000.00
UCL income_statement (quarterly, 2026-03-31) — Diluted Average Shares: 38080410.00
UCL income_statement (quarterly, 2026-03-31) — Diluted EPS: -0.10
UCL income_statement (quarterly, 2026-03-31) — Diluted NI Availto Com Stockholders: -3493000.00
UCL balance_sheet (quarterly, 2026-03-31) — Duefrom Related Parties Current: 28000.00
UCL income_statement (quarterly, 2026-03-31) — EBIT: -3466000.00
UCL income_statement (quarterly, 2026-03-31) — EBITDA: -3466000.00
UCL income_statement (quarterly, 2026-03-31) — Earnings From Equity Interest Net Of Tax: -2000.00
UCL cash_flow (quarterly, 2026-03-31) — Effect Of Exchange Rate Changes: 212000.00
UCL cash_flow (quarterly, 2026-03-31) — End Cash Position: 27998000.00
UCL cash_flow (quarterly, 2026-03-31) — Financing Cash Flow: 3629000.00
UCL cash_flow (quarterly, 2026-03-31) — Free Cash Flow: -8688000.00
UCL balance_sheet (quarterly, 2026-03-31) — Gains Losses Not Affecting Retained Earnings: 2310000.00
UCL income_statement (quarterly, 2026-03-31) — General And Administrative Expense: 2932000.00
UCL balance_sheet (quarterly, 2026-03-31) — Goodwill And Other Intangible Assets: 487000.00
UCL balance_sheet (quarterly, 2026-03-31) — Gross PPE: 2957000.00
UCL income_statement (quarterly, 2026-03-31) — Gross Profit: 8273000.00
UCL income_statement (quarterly, 2026-03-31) — Interest Expense: 56000.00
UCL income_statement (quarterly, 2026-03-31) — Interest Expense Non Operating: 56000.00
UCL income_statement (quarterly, 2026-03-31) — Interest Income: 3000.00
UCL income_statement (quarterly, 2026-03-31) — Interest Income Non Operating: 3000.00
UCL balance_sheet (quarterly, 2026-03-31) — Inventory: 4580000.00
UCL balance_sheet (quarterly, 2026-03-31) — Invested Capital: 36739000.00
UCL cash_flow (quarterly, 2026-03-31) — Investing Cash Flow: 14000.00
UCL balance_sheet (quarterly, 2026-03-31) — Investments And Advances: 2075000.00
UCL balance_sheet (quarterly, 2026-03-31) — Long Term Capital Lease Obligation: 461000.00
UCL balance_sheet (quarterly, 2026-03-31) — Long Term Debt: 1648000.00
UCL balance_sheet (quarterly, 2026-03-31) — Long Term Debt And Capital Lease Obligation: 2109000.00
UCL income_statement (quarterly, 2026-03-31) — Net Income: -3493000.00
UCL income_statement (quarterly, 2026-03-31) — Net Income Common Stockholders: -3493000.00
UCL income_statement (quarterly, 2026-03-31) — Net Income Continuous Operations: -3493000.00
UCL income_statement (quarterly, 2026-03-31) — Net Income From Continuing And Discontinued Operation: -3493000.00
UCL income_statement (quarterly, 2026-03-31) — Net Income From Continuing Operation Net Minority Interest: -3493000.00
UCL income_statement (quarterly, 2026-03-31) — Net Income Including Noncontrolling Interests: -3493000.00
UCL income_statement (quarterly, 2026-03-31) — Net Interest Income: -53000.00
UCL income_statement (quarterly, 2026-03-31) — Net Non Operating Interest Income Expense: -53000.00
UCL balance_sheet (quarterly, 2026-03-31) — Net PPE: 2957000.00
UCL balance_sheet (quarterly, 2026-03-31) — Net Tangible Assets: 25259000.00
UCL balance_sheet (quarterly, 2026-03-31) — Non Current Prepaid Assets: 56000.00
UCL income_statement (quarterly, 2026-03-31) — Normalized EBITDA: -3466000.00
UCL income_statement (quarterly, 2026-03-31) — Normalized Income: -3493000.00
UCL cash_flow (quarterly, 2026-03-31) — Operating Cash Flow: -8688000.00
UCL income_statement (quarterly, 2026-03-31) — Operating Income: -2674000.00
UCL income_statement (quarterly, 2026-03-31) — Operating Revenue: 16859000.00
UCL balance_sheet (quarterly, 2026-03-31) — Ordinary Shares Number: 380572660.00
UCL balance_sheet (quarterly, 2026-03-31) — Other Current Assets: 6657000.00
UCL balance_sheet (quarterly, 2026-03-31) — Other Current Borrowings: 9345000.00
UCL balance_sheet (quarterly, 2026-03-31) — Other Equity Adjustments: 2310000.00
UCL income_statement (quarterly, 2026-03-31) — Other Gand A: 2932000.00
UCL income_statement (quarterly, 2026-03-31) — Other Income Expense: -795000.00
UCL balance_sheet (quarterly, 2026-03-31) — Other Investments: 2075000.00
UCL balance_sheet (quarterly, 2026-03-31) — Other Non Current Liabilities: 42000.00
UCL income_statement (quarterly, 2026-03-31) — Other Non Operating Income Expenses: -795000.00
UCL balance_sheet (quarterly, 2026-03-31) — Other Properties: 2957000.00
UCL balance_sheet (quarterly, 2026-03-31) — Other Short Term Investments: 12693000.00
UCL balance_sheet (quarterly, 2026-03-31) — Payables: 3805000.00
UCL balance_sheet (quarterly, 2026-03-31) — Payables And Accrued Expenses: 21798000.00
UCL income_statement (quarterly, 2026-03-31) — Pretax Income: -3522000.00
UCL balance_sheet (quarterly, 2026-03-31) — Receivables: 4632000.00
UCL income_statement (quarterly, 2026-03-31) — Reconciled Cost Of Revenue: 8586000.00
UCL income_statement (quarterly, 2026-03-31) — Research And Development: 1628000.00
UCL balance_sheet (quarterly, 2026-03-31) — Retained Earnings: -219200000.00
UCL income_statement (quarterly, 2026-03-31) — Selling And Marketing Expense: 6387000.00
UCL income_statement (quarterly, 2026-03-31) — Selling General And Administration: 9319000.00
UCL balance_sheet (quarterly, 2026-03-31) — Share Issued: 380572660.00
UCL balance_sheet (quarterly, 2026-03-31) — Stockholders Equity: 25746000.00
UCL balance_sheet (quarterly, 2026-03-31) — Tangible Book Value: 25259000.00
UCL income_statement (quarterly, 2026-03-31) — Tax Effect Of Unusual Items: 0.00
UCL income_statement (quarterly, 2026-03-31) — Tax Provision: -31000.00
UCL income_statement (quarterly, 2026-03-31) — Tax Rate For Calcs: 0.01
UCL balance_sheet (quarterly, 2026-03-31) — Total Assets: 62135000.00
UCL balance_sheet (quarterly, 2026-03-31) — Total Capitalization: 27394000.00
UCL balance_sheet (quarterly, 2026-03-31) — Total Debt: 12234000.00
UCL balance_sheet (quarterly, 2026-03-31) — Total Equity Gross Minority Interest: 25746000.00
UCL income_statement (quarterly, 2026-03-31) — Total Expenses: 19533000.00
UCL balance_sheet (quarterly, 2026-03-31) — Total Liabilities Net Minority Interest: 36389000.00
UCL balance_sheet (quarterly, 2026-03-31) — Total Non Current Assets: 5575000.00
UCL balance_sheet (quarterly, 2026-03-31) — Total Non Current Liabilities Net Minority Interest: 2151000.00
UCL income_statement (quarterly, 2026-03-31) — Total Operating Income As Reported: -3469000.00
UCL balance_sheet (quarterly, 2026-03-31) — Working Capital: 22322000.00
UCM.AX income_statement (annual, 2021-06-30) — +Operating Expense: 4805732.00
UCM.AX income_statement (annual, 2021-06-30) — +Total Revenue: 3858081.00
UCM.AX balance_sheet (annual, 2021-06-30) — Accounts Payable: 135583.00
UCM.AX balance_sheet (annual, 2021-06-30) — Accounts Receivable: 225032.00
UCM.AX balance_sheet (annual, 2021-06-30) — Accumulated Depreciation: -927152.00
UCM.AX income_statement (annual, 2021-06-30) — Amortization: 56283.00
UCM.AX income_statement (annual, 2021-06-30) — Amortization Of Intangibles Income Statement: 56283.00
UCM.AX income_statement (annual, 2021-06-30) — Basic Average Shares: 149567171.00
UCM.AX income_statement (annual, 2021-06-30) — Basic EPS: -0.01
UCM.AX cash_flow (annual, 2021-06-30) — Beginning Cash Position: 1920657.00
UCM.AX cash_flow (annual, 2021-06-30) — Capital Expenditure: -33351.00
UCM.AX balance_sheet (annual, 2021-06-30) — Capital Lease Obligations: 1429934.00
UCM.AX balance_sheet (annual, 2021-06-30) — Capital Stock: 34665560.00
UCM.AX balance_sheet (annual, 2021-06-30) — Cash And Cash Equivalents: 1710554.00
UCM.AX balance_sheet (annual, 2021-06-30) — Cash Cash Equivalents And Short Term Investments: 1710554.00
UCM.AX balance_sheet (annual, 2021-06-30) — Cash Equivalents: 15215.00
UCM.AX balance_sheet (annual, 2021-06-30) — Cash Financial: 1695339.00
UCM.AX cash_flow (annual, 2021-06-30) — Cash Flow From Continuing Financing Activities: -281868.00
UCM.AX cash_flow (annual, 2021-06-30) — Cash Flow From Continuing Investing Activities: -33351.00
UCM.AX cash_flow (annual, 2021-06-30) — Cash Flowsfromusedin Operating Activities Direct: 54978.00
UCM.AX cash_flow (annual, 2021-06-30) — Changes In Cash: -260241.00
UCM.AX cash_flow (annual, 2021-06-30) — Classesof Cash Payments: -5426761.00
UCM.AX cash_flow (annual, 2021-06-30) — Classesof Cash Receiptsfrom Operating Activities: 5545107.00
UCM.AX balance_sheet (annual, 2021-06-30) — Common Stock: 34665560.00
UCM.AX balance_sheet (annual, 2021-06-30) — Common Stock Equity: 3077598.00
UCM.AX cash_flow (annual, 2021-06-30) — Common Stock Payments: -10870.00
UCM.AX income_statement (annual, 2021-06-30) — Cost Of Revenue: 485073.00
UCM.AX balance_sheet (annual, 2021-06-30) — Current Assets: 3451080.00
UCM.AX balance_sheet (annual, 2021-06-30) — Current Capital Lease Obligation: 189050.00
UCM.AX balance_sheet (annual, 2021-06-30) — Current Debt And Capital Lease Obligation: 189050.00
UCM.AX balance_sheet (annual, 2021-06-30) — Current Deferred Assets: 441283.00
UCM.AX balance_sheet (annual, 2021-06-30) — Current Deferred Taxes Assets: 441283.00
UCM.AX balance_sheet (annual, 2021-06-30) — Current Liabilities: 948835.00
UCM.AX income_statement (annual, 2021-06-30) — Depreciation Amortization Depletion Income Statement: 396252.00
UCM.AX income_statement (annual, 2021-06-30) — Depreciation And Amortization In Income Statement: 396252.00
UCM.AX income_statement (annual, 2021-06-30) — Depreciation Income Statement: 339969.00
UCM.AX income_statement (annual, 2021-06-30) — Diluted Average Shares: 149567171.00
UCM.AX income_statement (annual, 2021-06-30) — Diluted EPS: -0.01
UCM.AX income_statement (annual, 2021-06-30) — EBIT: -786690.00
UCM.AX income_statement (annual, 2021-06-30) — EBITDA: -390438.00
UCM.AX cash_flow (annual, 2021-06-30) — Effect Of Exchange Rate Changes: 50138.00
UCM.AX balance_sheet (annual, 2021-06-30) — Employee Benefits: 22391.00
UCM.AX cash_flow (annual, 2021-06-30) — End Cash Position: 1710554.00
UCM.AX cash_flow (annual, 2021-06-30) — Financing Cash Flow: -281868.00
UCM.AX balance_sheet (annual, 2021-06-30) — Finished Goods: 237045.00
UCM.AX balance_sheet (annual, 2021-06-30) — Foreign Currency Translation Adjustments: 84157.00
UCM.AX cash_flow (annual, 2021-06-30) — Free Cash Flow: 21627.00
UCM.AX balance_sheet (annual, 2021-06-30) — Gains Losses Not Affecting Retained Earnings: 3352406.00
UCM.AX income_statement (annual, 2021-06-30) — General And Administrative Expense: 2743677.00
UCM.AX balance_sheet (annual, 2021-06-30) — Goodwill And Other Intangible Assets: 469684.00
UCM.AX balance_sheet (annual, 2021-06-30) — Gross PPE: 2257900.00
UCM.AX income_statement (annual, 2021-06-30) — Gross Profit: 3373008.00
UCM.AX income_statement (annual, 2021-06-30) — Interest Expense: 95513.00
UCM.AX income_statement (annual, 2021-06-30) — Interest Expense Non Operating: 95513.00
UCM.AX income_statement (annual, 2021-06-30) — Interest Income: 31738.00
UCM.AX income_statement (annual, 2021-06-30) — Interest Income Non Operating: 31738.00
UCM.AX cash_flow (annual, 2021-06-30) — Interest Paid Direct: -95512.00
UCM.AX cash_flow (annual, 2021-06-30) — Interest Paid Supplemental Data: 95512.00
UCM.AX cash_flow (annual, 2021-06-30) — Interest Received Direct: 32144.00
UCM.AX balance_sheet (annual, 2021-06-30) — Inventory: 894877.00
UCM.AX balance_sheet (annual, 2021-06-30) — Invested Capital: 3077598.00
UCM.AX cash_flow (annual, 2021-06-30) — Investing Cash Flow: -33351.00
UCM.AX balance_sheet (annual, 2021-06-30) — Long Term Capital Lease Obligation: 1240884.00
UCM.AX balance_sheet (annual, 2021-06-30) — Long Term Debt And Capital Lease Obligation: 1240884.00
UCM.AX balance_sheet (annual, 2021-06-30) — Long Term Provisions: 45261.00
UCM.AX balance_sheet (annual, 2021-06-30) — Machinery Furniture Equipment: 923668.00
UCM.AX cash_flow (annual, 2021-06-30) — Net Common Stock Issuance: -10870.00
UCM.AX income_statement (annual, 2021-06-30) — Net Income: -924243.00
UCM.AX income_statement (annual, 2021-06-30) — Net Income Common Stockholders: -924243.00
UCM.AX income_statement (annual, 2021-06-30) — Net Income Continuous Operations: -924243.00
UCM.AX income_statement (annual, 2021-06-30) — Net Income From Continuing And Discontinued Operation: -924243.00
UCM.AX income_statement (annual, 2021-06-30) — Net Income From Continuing Operation Net Minority Interest: -924243.00
UCM.AX income_statement (annual, 2021-06-30) — Net Income Including Noncontrolling Interests: -924243.00
UCM.AX cash_flow (annual, 2021-06-30) — Net Intangibles Purchase And Sale: -27841.00
UCM.AX income_statement (annual, 2021-06-30) — Net Interest Income: -63775.00
UCM.AX income_statement (annual, 2021-06-30) — Net Non Operating Interest Income Expense: -63775.00
UCM.AX cash_flow (annual, 2021-06-30) — Net Other Financing Charges: -270998.00
UCM.AX balance_sheet (annual, 2021-06-30) — Net PPE: 1330748.00
UCM.AX cash_flow (annual, 2021-06-30) — Net PPE Purchase And Sale: -5510.00
UCM.AX balance_sheet (annual, 2021-06-30) — Net Tangible Assets: 2607914.00
UCM.AX balance_sheet (annual, 2021-06-30) — Non Current Pension And Other Postretirement Benefit Plans: 22391.00
UCM.AX income_statement (annual, 2021-06-30) — Normalized EBITDA: -390438.00
UCM.AX income_statement (annual, 2021-06-30) — Normalized Income: -924243.00
UCM.AX income_statement (annual, 2021-06-30) — Operating Income: -1432724.00
UCM.AX income_statement (annual, 2021-06-30) — Operating Revenue: 3858081.00
UCM.AX balance_sheet (annual, 2021-06-30) — Ordinary Shares Number: 155949331.00